Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062204 · ClinicalTrials.gov registry record · NA
Altrazeal™ Versus Aquacel® Ag for Partial Thickness Skin Donor Sites
A NA study, sponsored by ULURU.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01062204 is a NA study that has completed, run by ULURU. The registered enrollment target is 40 participants.
The verdict
NCT01062204, a NA study, has completed, sponsored by ULURU.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate the time to wound healing in skin graft donor sites with a new treatment (Altrazeal dressing) compared to standard of care treatment (Aquacel Ag- Carboxymethylcellulose dressing) in partial thickness skin graft donor sites.
Interventions
- DEVICE Altrazeal
- DEVICE Aquacel Ag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062204
The ClinicalTrials.gov registry entry for NCT01062204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ULURU, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Altrazeal is the first listed.
NCT01062204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062204 about?
NCT01062204 is a clinical study titled "Altrazeal™ Versus Aquacel® Ag for Partial Thickness Skin Donor Sites". The primary objective of the study is to evaluate the time to wound healing in skin graft donor sites with a new treatment (Altrazeal dressing) compared to standard of care treatment (Aquacel Ag- Carboxymethylcellulose dressing) in partial thickness skin graft donor sites.
What is the current status of trial NCT01062204?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2008-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01062204?
The interventions under investigation include: Altrazeal (DEVICE), Aquacel Ag (DEVICE).
Who is sponsoring clinical trial NCT01062204?
This trial is sponsored by ULURU, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.